Novo Nordisk Resubmits Insulin Icodec (Awiqli) Injection BLA: Novo Nordisk resubmitted its BLA to the FDA for insulin icodec (Awiqli) injection, a once-weekly basal insulin treatment for adults living with type 2 diabetes, following a July 2024 CRL
Eat smaller, more frequent meals, avoid high-fat and spicy foods, maintain adequate hydration (1.52 litres daily), and follow the prescribed dose escalation schedule
This system is designed for the co-delivery of cepharanthine and selenium
Both medications Brello Health offers are backed by strong trial data, separate from the platform itself
When you weigh more, muscles strengthen to support that weight
Take the first step to a healthier you Schedule an appointment now to experience our attentive and high-quality treatments